ADC Therapeutics (NYSE:ADCT) Research Coverage Started at Cantor Fitzgerald

Investment analysts at Cantor Fitzgerald began coverage on shares of ADC Therapeutics (NYSE:ADCT – Get Free Report) in a report released on Thursday, Marketbeat.com reports. The brokerage set an “overweight” rating on the stock. A number of other brokerages have also issued reports on ADCT. Guggenheim reissued a “buy” rating on shares of ADC Therapeutics […]

Related Keywords

Canada , ,Hennion Walsh Asset Management Inc ,Sanibel Captiva Trust Company Inc ,Acadian Asset Management ,Saxony Capital Management ,Therapeutics Company Profile ,Royal Bank ,Redmile Group ,Cantor Fitzgerald ,Get Free Report ,Walsh Asset Management ,Capital Management ,Captiva Trust Company ,Asset Management ,